Clinical studies have found that although SFRP3 can increase the survival rate of patients with chronic heart failure caused by ischemic cardiomyopathy; an elevated SFRP3 level means that the prognosis of patients with acute coronary syndrome is poor (12, 13). Here, FRZB is linked to acute coronary syndrome.